CLS Stock Recent News

Celestica's strong Q4 performance and robust FY2025 guidance, driven by AI tailwinds and data center spending, support a "Strong buy" rating. The stock's valuation is attractive, with a DCF model indicating a 38% upside potential, even under conservative growth assumptions. Celestica's financial flexibility, low RSI levels, and significant momentum make it well-positioned for continued growth and value creation.

Subscribers to Schaeffer's Weekend Trader options recommendation service received this CLS commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry and exit parameters.

Trump's tariffs cause short-term volatility, but long-term market impact is minimal; earnings remain the key focus for investors. The three countries in questions are Canada, China, and Mexico. This blog dives into several major companies domiciled in one of those three countries. In the long-term scheme of things the fundamentals of the companies behind these ADRs and stocks are likely to be more deterministic than any geopolitical factors.

Here is how Celestica (CLS) and Anterix (ATEX) have performed compared to their sector so far this year.

Celestica (CLS) possesses solid growth attributes, which could help it handily outperform the market.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Five high-flying non-US. tech stocks have strong revenue and earnings growth potential for 2025.

CLS is well poised for sustained growth backed by robust infrastructure investments, solid technology know-how and wide industry experience.

Invest in stocks of EAT, BFST, AZEK, CLS and BSX to tap their high efficiency levels.

ENS, PCRX, CLS and ENVA are four stocks with explosive relative price strength.